Literature DB >> 31735648

Low thoracic muscle radiation attenuation is associated with postoperative pneumonia following partial hepatectomy for colorectal metastasis.

Gregory van der Kroft1, David P J van Dijk2, Sander S Rensen3, Frank H Van Tiel4, Bianca de Greef5, Malcolm West6, Kris Ostridge7, Cornelis H C Dejong8, Ulf P Neumann9, Steven W M Olde Damink8.   

Abstract

BACKGROUND: Low skeletal muscle radiation attenuation (SM-RA) is indicative of myosteatosis and diminished muscle function. It is predictive of poor outcome following oncological surgery in several cancer types. Postoperative pneumonia is a known risk factor for increased postoperative mortality. We hypothesized that low SM-RA of the respiratory muscles at the 4th thoracic-vertebra (T4) is associated with postoperative pneumonia following liver surgery.
METHODS: Postoperative pneumonia was identified using prospective infection control data. Computed tomography body composition analysis was performed at the L3-and T4 level to determine SM-RA. Body composition variables were corrected for confounders and related to postoperative pneumonia and admission time by multivariable logistic regression.
RESULTS: Body composition analysis of 180 patients was performed. Twenty-one patients developed postoperative pneumonia (11.6%). Multivariable analysis showed that low T4 SM-RA as well as low L3 SM-RA were significantly associated with postoperative pneumonia (OR 3.65, 95% CI 1.41-9.49, p < 0.01) and (OR 3.22, 95% CI 1.20-8.61, p = 0.02, respectively).
CONCLUSION: Low SM-RA at either the L3-or T4-level is associated with a higher risk of postoperative pneumonia following CLRM resection.
Copyright © 2019 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Year:  2019        PMID: 31735648     DOI: 10.1016/j.hpb.2019.10.1532

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  6 in total

1.  Association between low preoperative skeletal muscle quality and infectious complications following gastrectomy for gastric cancer.

Authors:  Tsuneyuki Uchida; Ryuichi Sekine; Kenichi Matsuo; Gaku Kigawa; Takahiro Umemoto; Kazuhiro Kijima; Yoshikuni Harada; Tetsuji Wakabayashi; Yuki Takahashi; Toshimitsu Shiozawa; Hideyuki Oyama; Shiori Shibata; Kuniya Tanaka
Journal:  Surg Today       Date:  2021-01-25       Impact factor: 2.549

2.  Myosteatosis can Predict Unfavorable Outcomes in Advanced Hepatocellular Carcinoma Patients Treated With Hepatic Artery Infusion Chemotherapy and Anti-PD-1 Immunotherapy.

Authors:  Xiaoping Yi; Yan Fu; Qianyan Long; Yazhuo Zhao; Sai Li; Chunhui Zhou; Huashan Lin; Xiaolian Liu; Chang Liu; Changyong Chen; Liangrong Shi
Journal:  Front Oncol       Date:  2022-05-16       Impact factor: 5.738

3.  Myosteatosis Significantly Predicts Persistent Dyspnea and Mobility Problems in COVID-19 Survivors.

Authors:  Rebecca De Lorenzo; Anna Palmisano; Antonio Esposito; Chiara Gnasso; Valeria Nicoletti; Riccardo Leone; Davide Vignale; Elisabetta Falbo; Marica Ferrante; Marta Cilla; Cristiano Magnaghi; Sabina Martinenghi; Giordano Vitali; Alessio Molfino; Patrizia Rovere-Querini; Maurizio Muscaritoli; Caterina Conte
Journal:  Front Nutr       Date:  2022-04-08

4.  Is sarcopenia a risk factor for reduced diaphragm function following hepatic resection? A study protocol for a prospective observational study.

Authors:  S W M Olde Damink; Christian S Bruells; Gregory van der Kroft; Sebastian Johannes Johannes Fritsch; S S Rensen; Steffen Wigger; Christian Stoppe; Andreas Lambertz; Ulf Peter Neumann
Journal:  BMJ Open       Date:  2021-11-16       Impact factor: 2.692

5.  CT-Based Sarcopenic Nomogram for Predicting Progressive Disease in Advanced Non-Small-Cell Lung Cancer.

Authors:  Xiaoping Yi; Qiurong Chen; Jingying Yang; Dengke Jiang; Liping Zhu; Haipeng Liu; Peipei Pang; Feiyue Zeng; Changyong Chen; Guanghui Gong; Hongling Yin; Bin Li; Bihong T Chen
Journal:  Front Oncol       Date:  2021-10-08       Impact factor: 6.244

6.  The Role of Sarcopenia and Myosteatosis in Short- and Long-Term Outcomes Following Curative-Intent Surgery for Hepatocellular Carcinoma in a European Cohort.

Authors:  Franziska Alexandra Meister; Georg Lurje; Suekran Verhoeven; Georg Wiltberger; Lara Heij; Wen-Jia Liu; Decan Jiang; Philipp Bruners; Sven Arke Lang; Tom Florian Ulmer; Ulf Peter Neumann; Jan Bednarsch; Zoltan Czigany
Journal:  Cancers (Basel)       Date:  2022-01-30       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.